Comments on the adverse effect of concurrent pyridoxine administration on the efficacy of L-dopa in treating parkinsonism.
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D008954:Models, Biological; D010300:Parkinson Disease / Q000188:drug therapy*; D011736:Pyridoxine / Q000009:adverse effects*
D004295:Dihydroxyphenylalanine; D011736:Pyridoxine